Second Medical Center-Sofia

At Second Medical Center-Sofia, the clinical research portfolio includes studies in cardiovascular diseases focused on atrial fibrillation and stroke prevention. These trials are designed to evaluate new treatment options that may improve protection against stroke and systemic embolism while also assessing overall safety and treatment benefit.

• Prevention of stroke and systemic embolism in people with atrial fibrillation
• Evaluation of a new therapy compared with an established treatment
• Assessment of both effectiveness and bleeding risk

This work reflects a strong interest in improving care for patients with heart rhythm disorders and reducing serious clot-related complications.

The site also supports research in nutritional and metabolic diseases, with trials centered on hypertriglyceridemia and severe hypertriglyceridemia. These studies aim to test whether a new therapy can lower fasting serum triglyceride levels and offer better control of abnormal lipid levels in adults.

• Hypertriglyceridemia
• Severe hypertriglyceridemia
• Testing a treatment intended to reduce triglycerides

By focusing on elevated blood fats, the research at this hospital addresses an important risk factor linked to broader metabolic and cardiovascular health.